Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

New 2025 observational research on adults aged 40-65 finds BurnPeak’s Triple-BHB formulation supports measurable fat reduction, energy balance, and appetite control without stimulants.

Novo Nordisk (($NVO)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled ‘Descriptive ...

Menopause, the natural cessation of periods due to lower hormone levels, typically occurs between the ages of 45 and 55. The ...

NYU Langone’s Center for Multisite Studies is led by experts who are experienced in managing and supporting research.

Menopause may take a toll on women physically and emotionally due to declining estrogen levels. For some, the use of hormone ...

In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, ...

University of Florida Health writer Michelle Jaffee reports a bold finding: cancer patients who got a COVID-19 mRNA vaccine ...

A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and ...

It could lead to a lower risk of developing breast cancer or having a heart attack or stroke, analysis suggests ...

Researchers said further studies were needed but they hoped the findings can ‘start a larger conversation about prevention in ...